Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 8/20 | 0.60 |
| ▸ | CTSL | P07711 | 7/20 | 0.60 |
| ▸ | CTSS | P25774 | 10/20 | 0.57 |
| ▸ | CTSK | P43235 | 3/20 | 0.49 |
| ▸ | CTSH | P09668 | 1/20 | 0.49 |
| ▸ | CTSC | P53634 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TACR2 | P21452 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7410496 | 1.00 | CTSB (0.60) | CTSBCTSLCTSSCTSKCTSH | |
| SCHEMBL7414175 | 0.86 | CTSL (0.67) | CTSBCTSLCTSSCTSKCTSH | |
| SCHEMBL7414172 | 0.86 | CTSL (0.67) | CTSBCTSLCTSSCTSKCTSH | |
| SCHEMBL8691324 | 0.82 | CTSL (0.62) | CTSBCTSLCTSSCTSKCTSH | |
| SCHEMBL8691322 | 0.82 | CTSL (0.62) | CTSBCTSLCTSSCTSKCTSH | |
| SCHEMBL7410501 | 0.80 | ACACB (0.46) | CTSBCTSLPOLBRAB9ASMN1; SMN2 | |
| SCHEMBL7414216 | 0.79 | CTSL (0.70) | CTSBCTSLCTSSCTSKCTSH | |
| SCHEMBL8696030 | 0.79 | CTSL (0.70) | CTSBCTSLCTSSCTSKCTSH | |
| SCHEMBL8696034 | 0.79 | CTSL (0.70) | CTSBCTSLCTSSCTSKCTSH | |
| SCHEMBL7414213 | 0.79 | CTSL (0.70) | CTSBCTSLCTSSCTSKCTSH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5776718-A | Reversible protease inhibitors | ARRIS PHARMACEUTICAL CORPORATION (US) | 1998-07-07 | — | — | US | disclosed |
| EP-0817778-A1 | REVERSIBLE PROTEASE INHIBITORS | ARRIS PHARMACEUTICAL CORPORATION (US) | 1998-01-14 | — | — | EP | disclosed |
| WO-1996030353-A1 | REVERSIBLE PROTEASE INHIBITORS | ARRIS PHARMACEUTICAL CORPORATION (US) | 1996-10-03 | — | — | WO | disclosed |